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Integrative Physiology
Hyperphosphorylation of the Cardiac Ryanodine Receptor
at Serine 2808 Is Not Involved in Cardiac Dysfunction After
Myocardial Infarction
Hongyu Zhang,* Catherine A. Makarewich,* Hajime Kubo,* Wei Wang, Jason M. Duran, Ying Li,
Remus M. Berretta, Walter J. Koch, Xiongwen Chen, Erhe Gao, Héctor H. Valdivia, Steven R. Houser

Rationale: Abnormal behavior of the cardiac ryanodine receptor (RyR2) has been linked to cardiac arrhythmias
and heart failure (HF) after myocardial infarction (MI). It has been proposed that protein kinase A (PKA)
hyperphosphorylation of the RyR2 at a single residue, Ser-2808, is a critical mediator of RyR dysfunction,
depressed cardiac performance, and HF after MI.
Objective: We used a mouse model (RyRS2808A) in which PKA hyperphosphorylation of the RyR2 at Ser-2808 is
prevented to determine whether loss of PKA phosphorylation at this site averts post MI cardiac pump dysfunction.
Methods and Results: MI was induced in wild-type (WT) and S2808A mice. Myocyte and cardiac function were
compared in WT and S2808A animals before and after MI. The effects of the PKA activator Isoproterenol (Iso)
on L-type Ca2ⴙ current (ICaL), contractions, and [Ca2ⴙ]I transients were also measured. Both WT and S2808A
mice had depressed pump function after MI, and there were no differences between groups. MI size was also
identical in both groups. L type Ca2ⴙ current, contractions, Ca2ⴙ transients, and SR Ca2ⴙ load were also not
significantly different in WT versus S2808A myocytes either before or after MI. Iso effects on Ca2ⴙ current,
contraction, Ca2ⴙ transients, and SR Ca2ⴙ load were identical in WT and S2808A myocytes before and after MI
at both low and high concentrations.
Conclusions: These results strongly support the idea that PKA phosphorylation of RyR-S2808 is irrelevant to the
development of cardiac dysfunction after MI, at least in the mice used in this study. (Circ Res. 2012;110:831-840.)
Key Words: myocardial infarction 䡲 ryanodine receptor 䡲 heart failure 䡲 PKA hyperphosphorylation

M

yocardial infarction (MI)1 is a major cause of left
ventricular dysfunction that leads to heart failure (HF)
and arrhythmogenic sudden cardiac death.2 The development
of HF after MI involves remodeling at the molecular, cellular,
and organ levels and is characterized by ventricular dilatation,
elevated systolic wall stress, and poor cardiac pump function.
Dysregulated intracellular Ca2⫹ handling plays a major role
in the pathophysiology of contractile, electrophysiological,
and structural abnormalities that evolve after MI.3 There are
alterations in the abundance and phosphorylation state of
almost all Ca2⫹ regulatory proteins in the failing heart.4 –5
Collectively, these changes produce alterations in diastolic
and systolic Ca2⫹ and diminished responses to sympathetic
regulatory stimulation.6 –7 There is some evidence, primarily
from the Marks laboratory,8,9 that hyperphosphorylation of

the Ca2⫹ release channel (Ryanodine receptor; RyR2) plays a
significant independent role in the altered Ca2⫹ regulation of
the heart after MI. This idea was tested in the current study.

Editorial, see p 796
In This Issue, see p 795
Cardiac myocyte contraction occurs when the action potential activates voltage-gated L-type Ca2⫹ channels
(LTCCs)10 in the cell membrane and its invaginations, the
T-tubules. A small amount of Ca2⫹ influx through these
LTCCs triggers the release of much larger amount of Ca2⫹
from the sarcoplasmic reticulum (SR) through activation of
RyR2. This process is termed Ca2⫹-induced Ca2⫹ release,
and RyR2s are essential for this process.
LTCCs in T-tubules are in close proximity to the junctional
SR that contains RyRs, and together they form a “couplon,”11
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Non-standard Abbreviations and Acronyms
EF
FS
HF
ICaL
Iso
LTCC
MI
RyR
SR
WT

ejection fraction
fractional shortening
heart failure
L-type Ca2⫹ current
isoproterenol
L-type Ca2⫹ channel
myocardial infarction
ryanodine receptor
sarcoplasmic reticulum
wild-type

where Ca2⫹-induced Ca2⫹ release takes place. SR Ca2⫹
release within a couplon is regenerative and occurs when 1 or
more LTCCs open, to raise local junctional cleft [Ca2⫹], to
promote binding to RyRs, to cause their opening. The
resultant flux of SR Ca2⫹ into the junctional space further
elevates cleft Ca2⫹ and this activates other nearby RyRs to
induce locally regenerative Ca2⫹ release.12 In normal hearts,
all couplons within a cell appear to be activated with each
heart beat,11 and it is the sum of the Ca2⫹ release from all
couplons that produces the systolic Ca2⫹ transient that
activates the contractile apparatus.13 Relaxation occurs
through Ca2⫹ reuptake into the SR through the SR Ca2⫹
ATPase (SERCa) and Ca2⫹ extrusion through the Na/Ca
exchanger.14,15
Length-independent changes in the force of cardiac contraction (contractility) are critical to normal cardiac function
and are largely brought about by altering the amplitude and
duration of the systolic [Ca2⫹] transient. Contractility is
efficiently regulated in the normal heart and this primarily
results from activation of adrenergic signaling pathways
through protein kinase A (PKA). Ca2⫹ regulatory PKA
targets include the LTCC (to increase Ca2⫹ current and SR
Ca2⫹ load), phospholamban (to increase the activity of
SERCa, promote more rapid removal of Ca2⫹ from the
cytoplasm and to help increase SR Ca2⫹ loading),16 and RyR
(to increase Ca2⫹ dependent opening).16,17 The roles of
PKA-mediated LTCC and SERCa regulation in the normal
control of cardiac contractility are widely accepted.18,19 However, the independent role of PKA-mediated regulation of
RyR2 activity as a major regulator of cardiac contractile
strength is not broadly supported in the literature.20 This
effect is predicted from the fact that increasing the Ca2⫹dependent opening probability of RyR2 should not increase
the number of couplons that release stored Ca2⫹, since all
couplons participate in normal EC coupling.21–23
In cardiac disease, the contractile demands on the heart are
persistently increased, and chronic activity of the sympathetic
nervous system is needed to maintain cardiac output.24 This
heightened hyperadrenergic state of the stressed heart is
thought to contribute to depression of contractility reserve
and cardiac arrhythmias.25 Many studies have shown that
deranged Ca2⫹ handling in heart failure involves altered
SERCa activity and reduced LTCC abundance with increased

activity.6,26 –27 The Marks laboratory has proposed that abnormal PKA-mediated phosphorylation of RyR2 (at Serine
2808) is centrally involved in defective Ca2⫹ handling in
HF.9,28 PKA-mediated hyperphosphorylation of RyR at
S2808 is proposed to increase RyR Ca2⫹-dependent opening
(leak), leading to depletion of SR Ca2⫹ stores.9 Studies by the
Marks group have shown that PKA-mediated hyperphosphorylation of RyR2 at serine-2808 is a critical mediator of
normal cardiac contractility regulation29,30 and cardiac dysfunction after MI.8 These ideas were explored in experiments
with genetically modified mice in which Ser-2808 is mutated
to alanine (S2808A), to eliminate PKA-mediated phosphorylation.29 In previous studies, we31 and others32 were unable
to show any alterations in sympathetic regulation of cardiac
or myocyte function in RyR S2808A mice. Given the critical
nature of this topic, we studied if prevention of RyR2
phosphorylation after MI preserved cardiac function and
reduced premature death, consistent with the development of
cardiac dysfunction after MI being dependent on PKA phosphorylation of a single amino acid on RyR2.
In the present study, we examined if the absence of PKA
phosphorylation of RyR at Ser-2808 (RyRS2808A mice)
reduced the damaging effects of MI on cardiac structure and
function. Cardiac performance was compared before and after
MI in wild-type (WT) and RyRS2808A mice. Isoproterenol
(Iso) effects on L-type Ca2⫹ current (ICaL), contractions and
[Ca2⫹]I transients were also measured. Our results showed
that both WT and S2808A mice have depressed pump
function after MI, but we could not show a difference
between groups. MI size was identical in both groups. L-type
Ca2⫹ current, contractions, and [Ca2⫹]I transients were also
not significantly different in WT versus S2808A mice myocytes either before or after MI. Iso effects on Ca2⫹ current,
contraction, and Ca2⫹ transients were identical in WT and
S2808A myocytes before and after MI at both low and high
concentrations. These results strongly support the idea that
PKA phosphorylation of RyR-S2808 plays little or no role in
the development of cardiac dysfunction after MI in these
mice.

Methods
All methods have been described in detail in previous reports and are
described in detail in the Online Supplement. Briefly, myocardial
infarction was induced in WT and S2808A mice by permanent
occlusion of the left anterior descending coronary artery.33 Cardiac
function was measured with echocardiography. At the time of death,
hearts were removed and used for functional studies (isovolumic
hearts and isolated myocytes), tissue was used for Western or
biochemical analyses, or hearts were fixed and processed for
histological studies.

Results
Cardiac Function In Vivo After MI
MI was induced by permanent ligation of the left anterior
descending coronary artery. Before MI, there was no significant difference in cardiac function or structure between WT
and RyR-S2808A mice. Ejection fraction (EF), fractional
shortening (FS), left ventricle internal diameter, and septum
wall thickness were not different in WT and RyR-S2808A
mice (Figure 1). These data are consistent with those we have
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Figure 1. Cardiac structure and function are not
different in WT and S2808A animals before or
after MI. Ejection fraction (A), fractional shortening
(B), LV internal diameter (C), and septum wall
thickness (D) were measured with echocardiography before and 1 and 4 weeks after MI. *P⬍0.05,
**P⬍0.01 between pre-MI and post-MI within
groups.

previously reported.31 One week after MI, both groups of
mice had significant decreases of EF (pre-MI versus 1 week
post-MI; WT: 58.14⫾2.81 versus 32.87⫾3.88; S2808A:
61.59⫾3.57 versus 26.90⫾3.36) and fractional shortening
(pre-MI versus 1 week post-MI; WT: 29.08⫾2.72 versus
15.68⫾2.05; S2808A: 32.92⫾2.73 versus 12.13⫾1.90) (Figure 1A and 1B), but there was no significant difference
between WT and S2808A mice. Four weeks after MI, EF and
FS were still depressed and there were no differences between
WT and S2808A hearts (WT versus S2808A; EF:
25.65⫾1.90 versus 27.14⫾4.07; FS: 12.82⫾2.08 versus
11.94⫾0.93). There were significant changes in ventricular
geometry and wall thickness after acute MI. The LV was
dilated in all hearts and chamber size was significantly
increased in the first week and 4 weeks after MI (Figure 1C).
Septum wall thickness was decreased significantly in the first
week after MI in both groups and became stable at the end of
4 weeks (Figure 1D). There were no significant differences in
geometry or wall thickness between WT and S2808A mice
after MI.

Survival and Cardiac Phenotype After MI
Animals were studied for 4 weeks after MI surgery. There
was no significant difference in survival between WT and
S2808A mice (87% of all animals survived the 4-week study
interval). Heart weight was significantly greater in MI mice
compared with sham mice (Figure 2A), but there was no
difference between control and S2808A hearts. Lung weight
was also significantly increased after MI in S2808A mice,
suggesting more severe heart failure. Liver weight was
slightly increased in S2808A mice, but there was no significant difference between the groups 4 weeks after MI (Figure
2B and 2C). These data show that after MI, both WT and
S2808A mice had cardiac dysfunction with signs of acute HF.
We were unable to show any significant benefit in survival,
structure, or function in S2808A versus WT mice.

Infarct Length and Fibrosis Were Not Different in
WT and S2808A Mice
Infarct length was measured 4 weeks after MI. There was no
significant difference in infarct length between WT and

S2808A mice (WT versus S2808A: 32.55⫾2.38% versus
26.55⫾3.03%) (Figure 2D). Representative examples of infarcted cardiac tissue and fixed heart tissue sections are
shown in Online Figure I, A through C. We also measured
fibrosis in noninfarcted (remote) zones of infarcted hearts.
The collagen content in the remote zone was not significantly
different in WT and S2808A infarcted hearts (Figure 2E).
These data show that WT and S2808A mice had similar
infarct size and fibrotic remodeling after MI.

Western Blot Analysis
If PKA-mediated RyR-S2808 phosphorylation plays a critical
role in either the normal physiology of the mouse heart or in
the progression of cardiac dysfunction after MI, then eliminating this site would be expected to induce adaptive alterations in other Ca2⫹ regulatory proteins, as shown in other
studies.34 Ca2⫹ regulatory proteins including the L-type Ca2⫹
channel ␣1C subunit, phospholamban, total and phosphorylated at Thr-17 (PLBt, PT17), RyR2 total protein (RyRt), and
RyR2 phosphorylated at S2808 (RyRp) were measured with
Western analysis in sham and MI mice (representative blots
are shown in Online Figure II). Average data are shown in
Figure 3. There was no significant difference in the abundance of any of these Ca2⫹ regulatory proteins between WT
and S2808A mice either in sham or MI groups (Figure 3).
There was a significant increase of PLB phosphorylation at
Threonine17 in both WT and S2808A hearts after MI, but
there were no differences between the groups. An antibody
against phosphorylated RyR-Ser2808 did not react to RyRS2808A samples. RyR Ser2808 phosphorylation was significant in sham hearts and increased after MI (Online Figure II
and Figure III). These results show that there are no significant differences in Ca2⫹ regulatory protein abundance or
phosphorylation either before or after MI in WT versus
S2808A hearts. These results are inconsistent with a significant role for Ser2808 phosphorylation in the normal physiology of the mouse heart or in the deranged structure and
function after MI.
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Figure 2. MI causes cardiac remodeling and
fibrosis in WT and S2808A hearts. A through C,
Heart weight (HW), lung weight (LW), and liver
weight (LiverW) normalized to body weight (BW)
(HW/BW, LW/BW, LiverW/BW) in sham- and
MI-operated mice after 1 and 4 weeks surgery. D,
Infarct length 4 weeks after MI. E, Fibrotic area
(blue) in remote zones of trichrome-stained cardiac
histological sections was measured 4 weeks after
MI. $P⬍0.05 between WT and S2808A mice.
**P⬍0.01 between sham and MI.

LTCC Current (ICa,L) in S2808A Mice After MI
Elimination of a critical element in normal EC coupling or in
the regulation of the contractile response to stress would be
expected to have a major effect on baseline cardiac function.

If not, as we have shown in this and other studies,31 then
significant adaptation of related molecules would be needed
to offset the defective or lost protein. An example would be
the conditional NCX knockout mouse34 that survives with

Figure 3. Western analysis of Ca2ⴙ regulatory
proteins in WT and S2808A mice 4 weeks after
MI. A through E, Total RyR (RyRt), S2808 phosphorylated RyR (RyRp), LTCC alpha1C, SERCa2,
and phosphorylated Phospholamban (PT17) are
shown. The phosphorylated forms of RyR2 and
PT17 increased in MI hearts. *P⬍0.05, **P⬍0.01
versus sham.

Downloaded from http://circres.ahajournals.org/ at Thomas Jefferson Universi on August 17, 2013

Zhang et al

RyRS2808 Is Irrelevant to Heart Failure

835

Figure 4. L-type Ca2ⴙ current (ICa,L) in
sham and post-MI myocytes. A, Representative ICa,L in sham or post-MI myocytes from WT and S2808A hearts. B,
Representative ICa,L after 1 mol/L isoproterenol in sham or post-MI myocytes from
WT and S2808A hearts. C and D,
Current-voltage relationships in sham and
MI myocytes ⫾Iso. E and F, Peak ICa,L
and voltage dependence of ICa,L activation in sham or post-MI myocytes ⫾Iso
from WT and S2808A hearts. #P⬍0.05
between ⫾Iso.

adaptive reduction in the L-type Ca2⫹ current density. If
phosphorylation of RyR at Ser-2808 is critical to the regulation of EC coupling in health and disease, then its loss should
either induce a significant basal phenotype (which it did not)
or there should be adaptive changes in other EC coupling
proteins. The major protein that would be expected to change
would be the L-type Ca2⫹ channel, with a known essential
role in EC coupling. Therefore, we measured ICa-L density
and responsiveness to catecholamines. Peak ICa,L density was
not significantly different in WT and S2808A myocytes after
sham operations (WT sham: ⫺10.71⫾1.78 pA/pF, n⫽6;
S2808A sham: ⫺11.35⫾2.18 pA/pF, n⫽5). Isoproterenol
(Iso) increased ICa,L similarly in both WT and S2808A
myocytes (sham WT after Iso: 16.55⫾0.58 pA/pF n⫽5; sham
S2808A after Iso: 17.95⫾3.82 pA/pF, n⫽5) (Figure 4A
through 4C). Iso also caused similar hyperpolarizing shifts (a
signature of PKA phosphorylation effect) in the voltage
dependence of ICa,L activation in sham control and S2808A
myocytes (Online Figure III, A). After MI, there was also no
difference in peak ICa,L in WT and S2808A myocytes (WT
MI: ⫺11.76⫾2.1pA/pF, n⫽7; S2808A MI: ⫺9.00⫾0.98
pA/pF, n⫽7). Iso increased ICa,L significantly in both WT
(⫺16.2⫾2.7 pA/pF, n⫽7) and S2808A (⫺15.2⫾3.0 pA/pF,
n⫽7) myocytes, but again no significant difference was
detected between groups (Figure 4A, 4B, and 4D). The
voltage dependence of activation of ICa,L in S2808A myocytes was not significantly different than control myocytes
either before or after Iso treatment (Online Figure III, B).
Collectively, these data show that there are no significant

changes in LTCC density or PKA regulation in RyR-S2808A
mice either before or after MI.

Contractions and [Ca2ⴙ]i Transients in WT and
S2808A Mice Before and After MI
Twitch contractions and [Ca2⫹]i transients were studied at 0.5
and 2 Hz in the absence and presence of Iso (representative
data are shown in Online Figure IV and V). Low and high
concentrations of Iso were tested because others have suggested that differences in catecholamine responsiveness of
WT and S2808A myocytes are only observed at low concentrations.29 The rationale for this is unclear since the hyperphosphorylation hypothesis predicts that differences between
WT and S2808A animals should be most robust when WT
RyR is hyperphosphorylated. Nevertheless, we compared the
effects of lower [Iso] on WT and RyR-S2808A animals and
myocytes.
There were no significant differences in the amplitude of
contraction (FS) or the [Ca2⫹]i transients between WT or
S2808A myocytes (0.5 and 2 Hz) either before or after MI.
Low and high [Iso] caused identical changes in contraction
and [Ca2⫹]i transients in both groups under all conditions
tested (Figures 5 and 6). Low [Iso] (10 nmol/L) caused robust
increases in contraction and [Ca2⫹]i transients in all myocytes, and there were no differences between WT and
S2808A myocytes at any tested pacing rate or with or without
MI. High [Iso] did not increase the amplitude of contraction
or the [Ca2⫹]i transient beyond that produced by 10 nmol/L
Iso in either group under any conditions tested. These results
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Figure 5. Low and high [Iso] had identical effects on contractions of WT and S2808A myocytes from sham and MI hearts. A and
B, Myocyte contractions ⫾Iso in sham and post-MI myocytes. C and D, Average half-width (ms) of fractional shortening ⫾Iso in WT
and S2808A myocytes from sham or post-MI hearts. E and F, Average time to 50% relaxation (ms) of fractional shortening ⫾Iso in WT
and S2808A myocytes from sham or post-MI hearts. *P⬍0.05 sham versus MI, #P⬍0.05 between ⫾Iso; 10 and 100 nmol/L Iso were
used in this study.

do not support the hypothesis that the loss of PKA-mediated
phosphorylation of RyR2 at S2808 has any effect on baseline
cardiac myocyte function in the absence or presence of low or
high [Iso].
MI induced changes (half-width and tau) in the duration of
contractions and [Ca2⫹]i transients (Figures 5 and 6 and
Online Figures IV and V). These changes were identical in
WT and S2808A mice. Slowing and prolongation of contraction after MI probably results from changes in a host of
processes, but changes in phosphorylation of RyR2 at
S2808A do not appear to be a central element of this
functional remodeling.
Low and high [Iso] was also tested in vivo (Online Figure
VI), and we could not define a difference in effects in WT and
S2808A animals. These results are similar to those we have
shown previously in isolated hearts from these animals.31
Collectively, these results suggest that PKA-mediated phosphorylation of RyR-S2808 is not critical modulator of myocyte function in health or disease, at least under our
conditions.

SR Ca2ⴙ Load in WT and S2808A Myocytes
SR Ca2⫹ load is often decreased in myocytes isolated from
failing hearts,35 and this is thought to be, at least in part, due

to an abnormal “leak” of Ca2⫹ from the SR. PKA-mediated
hyperphosphorylation of RyR at S2808 has been proposed as
the mechanism that leads to SR “leak” and a reduction in
SR Ca2⫹ stores in hyperadrenergic states,36 but other
studies suggest that CaMKII mediated RyR phosphorylation at an alternative site is the cause of this “leak.”37 In the
present experiments, SR Ca2⫹ load was measured as the
caffeine releasable SR Ca2⫹ transient (Figure 7). The
effects of Iso on SR Ca2⫹ load were determined in sham
and MI myocytes ⫾Iso.
There were no significant differences in SR Ca2⫹ load or
the decay rate of these transients (not shown) between WT
and S2808A myocytes under control conditions (Figure 7C).
Iso caused a significant increase in SR Ca2⫹ load in both WT
and S2808A myocytes (Figure 7C), and the extent or rate of
decay (not shown) was not different.
MI caused a significant reduction in SR Ca2⫹ load in both
WT and S2808A myocytes, and there were no differences
between groups (Figure 7C). Iso had very small effects on SR
Ca2⫹ load in MI myocytes, and again there were no differences between groups (Figure 7C). These results do not
support the hypothesis that hyperphosphorylation of RyR at
S2808 is critical to the SR Ca2⫹ leak that develops after MI.
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Figure 6. Low and high [Iso] had identical effects on Ca2ⴙ transients of WT and S2808A myocytes from sham and MI hearts. A
and B, Myocyte peak Ca2⫹ transients ⫾Iso in sham and post-MI myocytes. C and D, Half-width of Ca2⫹ transients ⫾Iso in myocytes
from sham or post-MI hearts. E and F, Average tau of Ca2⫹ transients ⫾Iso in myocytes from sham or post-MI hearts. *P⬍0.05
between sham and MI, #P⬍0.05 between ⫾Iso.

Discussion
The present study evaluated the hypothesis that PKAmediated phosphorylation of RyR-S2808 is critical for the
normal regulation of cardiac contractility and that RyR
hyperphosphorylation is critical for the cardiac dysfunction
that develops after MI. Although the RyR hyperphosphorylation hypothesis has been supported by some previous
studies,8 the topic is still controversial,38,39 and many critical
issues have not been resolved.
In the normal heart, contractility is primarily regulated by
the sympathetic nervous system. To increase myocyte contractility, sympathetic signaling cascades activate PKA. The
PKA target proteins that become phosphorylated include the
LTCC, PLB, RyR, and troponin C. Increased myocyte contractility involves an increased amplitude and reduced duration of the systolic [Ca2⫹] transient. The contribution of
increased Ca2⫹ influx through the phosphorylated LTCC
complex and increased Ca2⫹ uptake by the SR after PLB
phosphorylation are well described in many laboratories.40
The idea that PKA-mediated phosphorylation of RyR plays a
critical role in the regulation of cardiac contractility is less
well accepted and is not supported by modeling studies.41
Studies with a S2808A mouse from the Marks group support

a significant role for RyR2 phosphorylation at S2808 in the
normal regulation of cardiac contractility29,30 and in the
response of the heart to pathological stress.8 The present
results with a similar mouse are inconsistent with these
previous reports.
MI reduces functional cardiac mass, and a hyperadrenergic
state is required to maintain cardiac pump function. The
persistent hyperadrenergic state eventually contributes to
abnormal myocyte function42 and death43 that precipitates
heart failure. The question posed here was if preventing
phosphorylation of RyR2 at a single amino acid is sufficient
to reduce adverse functional and structural remodeling after
MI. Our results suggest that eliminating PKA-mediated
phosphorylation at RyRS2808 has no impact on remodeling
after MI, at odds with results of studies discussed below.
A number of reports8,17,30,44strongly support the hypothesis
that PKA-mediated phosphorylation of RyR at S2808 causes
the RyR-associated protein FKBP12.6 (also called Calstabin)
to dissociate from RyR and that this increases the Ca2⫹
dependent opening of RyR. Hyperphosphorylation of RyR2
by PKA has been proposed as the cause of RyR “leak” that
leads to reduced SR content and contractility in HF.8 However, there is equally compelling data suggesting that PKA-
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Figure 7. Sarcoplasmic reticulum Ca2ⴙ content is identical in WT and S2808A myocytes from sham and MI
hearts. Caffeine-induced SR
Ca2⫹ release was measured in
WT and S2808A myocytes
⫾Iso (10 nmol/L) from sham or
MI mice. A and B, Examples of
Ca2⫹ transients elicited by 0.5
Hz of electric field stimulation
(first 4 traces) followed by
Ca2⫹ transients induced by
caffeine (fifth large trace; peak
indicates SR Ca2⫹ content). C,
Average amplitudes of
caffeine-induced Ca2⫹ transients ⫾Iso in WT and S2808A
myocytes. *P⬍0.05 between
sham and MI, #P⬍0.05
between ⫾Iso.

mediated phosphorylation of RyR at S2808 has little or no
role in the regulation of myocyte function in the normal or
diseased heart.31–32,38 There are studies showing that there are
no appreciable differences in the level of phosphorylation of
RyR2 and basal channel activity between failing and nonfailing canine hearts.38 S2808A animals with pressure overload
did not have better function than WT animals.32 In addition,
we have previously suggested that phosphorylation of RyR2
at Ser-2808 is not involved in the adrenergic regulation of
normal cardiac contractility.31 These data are consistent with
a detailed modeling study from the Bers group23 that predicts
that increasing RyR Ca2⫹-mediated opening should have very
little effect on contractility. In addition, others have shown
that CaMKII-mediated phosphorylation of RyR at S2814
rather than PKA-mediated phosphorylation of S2808 is responsible for regulation of RyR function45 and that PKA
phosphorylation of RyR does not induce significant displacement of FKBP from RyR2.46 The results we report in the
present investigation are consistent with those that have been
unable to document any significant role for RyRS2808
phosphorylation in health and disease.
We were unable to find any significant difference in any
Ca2⫹ regulatory process in S2808A mice. Our logic for
looking at other molecules involved in EC coupling and the
regulation of cardiac contractility in S2808A mice was that
because everyone agrees that S2808A mice have no basal
phenotype, either S2808 phosphorylation is unimportant or

there are adaptive changes in other proteins involved in the
regulation of myocyte Ca. An example of this in mouse
models is the conditional cardiac Na/Ca2⫹ exchanger (NCX)
KO that was expected to die after eliminating the major Ca2⫹
efflux mechanism in the normal heart, but did not die.34 It was
shown that these mice were able to live with a large reduction
in Ca2⫹ efflux by an adaptive reduction in Ca2⫹ influx
through the L-type Ca2⫹ channel.34 If RyR-S2808 phosphorylation is a critical component of the physiological regulation
of cardiac contractile function, then related adaptations would
be expected because there is no basal phenotype. We were
unable to detect any change in abundance, phosphorylation,
or function of any Ca2⫹ regulatory protein involved in Ca2⫹
entry or efflux and SR Ca2⫹ uptake, storage, and release.
We were unable to detect any beneficial effect of loss of
RyRS2808 phosphorylation after MI. Importantly we were
able to show reduced SR Ca2⫹ loading in MI myocytes, but
there were similar reductions in WT and S2808A myocytes.
These results support the idea that alterations in SR Ca2⫹
uptake, storage, and release are involved in post MI functional remodeling but do not support a role for hyperphosphorylation of RyR S2808 in these changes.
It is difficult to find common ground with those studies that
have reported such strong evidence for the RyRS2808 hyperphosphorylation hypothesis.8 A recent report29 suggested that
the reason for the differences between those studies finding
and not finding different catecholamine effects in WT versus
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S2808A mice is related to the fact that studies not detecting
differences used Iso concentrations that were too high.
Interestingly, there were already data in the literature using
low [Iso] that did not support this notion. A previous study31
showed that exposing WT and RyR2808A isovolumic hearts
to 10 nmol/L Iso caused identical increases in contractility in
both groups, whereas when a 10-fold higher concentration
(100 nmol/L) of Iso was used in the recent studies from the
Marks laboratory, reduced Iso effects were seen in S2808A
hearts. Because of this concentration issue, we tested the
effects of lower [Iso] on isolated myocyte function and could
not find any difference in effects in WT and S2808A cells.
Therefore, our present and previous results do not support the
idea that low doses of catecholamines are required to demonstrate differences in cardiac function related to RyR-S2808
phosphorylation. We are at a loss to find an explanation for
the differences between our data and those studies documenting a critical role for this single amino acid in the
regulation of cardiac function in health and disease. One
potential explanation for the differences in the literature
could be that the 2 sets of S2808A mice have a different
genetic background.
In summary, our results do not support a major role of
S2808 PKA phosphorylation on myocyte contractility regulation in health and disease.
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Novelty and Significance
What Is Known?
●

●

●

After myocardial infarction (MI), sympathetic regulatory pathways are
activated (with heightened activity of protein kinase A [PKA]) to
increase the contractility of surviving myocytes and thereby
maintain cardiac pump performance.
Some studies propose that PKA-mediated hyperphosphorylation of
a single serine (S2808) on the ryanodine receptor (RyR;
responsible for Ca2⫹ release from the sarcoplasmic reticulum
[SR] is a critical determinant of myocyte contractile and
electric dysfunction after MI.
Other studies have suggested that phosphorylation of RyRS2808 is
not an essential regulator of RyR function in health and disease.

What New Information Does This Article Contribute?
●

●
●

Preventing phosphorylation of RyR at S2808 (with an alanine
substitution; RyRS2808A) does not induce a significant change in
cardiac function or in the contractile response to adrenergic
agonists, at either low or high concentrations.
MI induced similar reductions in cardiac function and myocyte
adrenergic responsiveness in wild-type and RyRS2808A mice.
Changes in Ca2⫹ regulatory processes after MI, including a reduction
in SR Ca2⫹ stores, were similar in wild type and RyRS2808A mice,

documenting the lack of functional benefit of preventing PKA
phosphorylation of S2808 after MI.

MI causes regional cellular death in the heart and results in
depressed cardiac pump function. Heightened adrenergic signaling with activation of PKA helps maintain cardiac function
after MI but eventually causes myocyte dysfunction. Some
investigators have suggested that PKA-mediated phosphorylation of RyR at S2808 is critical to the normal regulation of
cardiac contractile function and that hyperphosphorylation of
S2808 is responsible for SR disturbances that reduce contractility and promote arrhythmias in disease, making hyperphosphorylation of S2808 a therapeutic target. The results of our
study show that RyRS2808 phosphorylation increases after MI
and that SR Ca2⫹ stores are reduced, consistent with SR Ca2⫹
“leak” hypothesis. However, preventing RyRS2808 phosphorylation had no effect on adrenergic regulation of myocyte or heart
function in the normal heart, and it did not prevent depressed
function after MI or reductions in SR Ca2⫹ loading after MI. Our
results show that, at least under the experimental conditions
used, PKA-mediated phosphorylation of RyR at S2808 is not a
critical regulator of cardiac contractile function in the normal
heart and that it might not be the mechanism that reduces SR
Ca2⫹ loading and myocyte contractility reserve after MI.
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Detailed Methods
Mice and Experimental Protocol WT and RyR-S2808A mice were used in these
studies. The methods used to generate the RyR-S2808A mouse have been described
previously1. Experiments were performed based on the National Institutes of Health
Guide for the Care and Use of Laboratory Animals, and all procedures were approved by
the Temple University Committee on Animal Care. Myocardial infarction (MI) surgeries
were carried out in mice at the age of 4 months. Mice were anesthetized with 2%
isoflurane inhalation. A skin incision was made over the left thorax, and the pectoral
muscles were retracted to expose the ribs. At the level of the fifth intercostal space, the
heart was exposed and pumped out through an expanded space between ribs. A
permanent knot or slipknot (for reperfusion purpose) was made around the left anterior
descending coronary artery (LAD) 2–3 mm from its origin with a 6-0 silk suture. The
heart was immediately placed back into the intrathoracic space after the knot was tied,,
followed by manual evacuation of pneumothoraces and closure of muscle and the skin
suture by means of the previously placed purse-string suture. Sham-operated animals
were subjected to the same surgical procedures except that the suture was passed
under the LAD but was not tied 2-3.
Determination of Left Ventricle Infarct Size After MI After mouse was anesthetized;
heart was quickly removed and frozen in a dish placed on dry ice for a few minutes.
Then the heart was quickly sliced into eight 1.2-mm-thick sections perpendicular to the
long axis of the heart. The sections were incubated in PBS containing 2%
triphenyltetrazolium chloride (TTC; Sigma) at room temperature for 15 min and digitally
photographed. TTC-negative staining area (infarcted myocardium) and total
circumference of section were measured by NIH Image J software. Myocardial infarction
size (expressed as percentage) was calculated using infarct length divided by total
circumference of tissue sections.
In-vivo Functional Analysis (Echocardiography, ECHO) ECHO was performed with
VisualSonics Velvo 770 machine which is specifically designed for mice and rats. Mice
were anesthetized with 2% isoflurane initially and then 1% during the ECHO procedure.
Hearts were viewed in the short-axis between the two papillary muscles and analyzed in
M-mode. Parameters were to be measured offline (Velvo software) including enddiastolic diameter (EDD), end-systolic diameter (ESD), posterior wall thickness (PWT),
and septal wall thickness (SWT) to determine cardiac morphological changes and
ejection fraction (EF), heart rate and fractional shortening (FS).
Histology Animals were anesthetized by sodium pentobarbital (0.1ml/100g) and
heparinized intravenously. Hearts were excised, trimmed off excess tissue, weighed,
washed and then perfused with 10% buffered formalin. The fixed heart tissues were
dehydrated, embedded in paraffin, sectioned at 5-μm thickness, and then perform
Masson’s Trichrome staning, which was used to evaluate gross morphology, fiber
integrity or fibrosis. Images were acquired using SPOTINSIGHT software (Diagnostic
Instruments Ins.). 3 fields were captured from each tissue section per heart and blue
area were automatically analyzed using Metamorph 6.1 software (Universal Image
Corp.). Average blue area percentage was calculated across at least 3 independent
hearts.
Cellular Functional Analysis Myocytes were isolated from sham and post-MI animals’
hearts at the end of 2-3 weeks to measure cellular fractional shortenting (FS), calcium
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transients ([Ca2+]i)and L-type calcium current (ICaL). All experiments were done a 35-37oC,
in superfused myocyte chambers mounted on fluorescence equipped microscopes. All
myocytes were characterized with the same series of experiments. The detailed
medthods are described as below.
Myocyte Isolation
Mice were anesthetized with sodium pentobarbital (0.1ml/100g). The heart was excised,
weighed and cannulated on a constant-flow langendorff apparatus. The heart was
digested by retrograde perfusion of normal tyrode solution containing 180 U/mL
collagenase and (mM): CaCl2 0.02, glucose 10, HEPES 5, KCl 5.4, MgCl2 1.2, NaCl
150, sodium pyruvate 2, pH 7.4. When the tissue has softened, left ventricular tissue is
gently minced, filtered, and equilibrated in Tyrodes solution with 0.2 mM CaCl2, and 1%
bovine serum alumin( BSA) at room temperature. Routinely, our initial yield is >90% rodshaped VMs, and >80% calcium-tolerant, rod-shaped VMS survive by the end of the
isolation.
ICaL Measurement ICaL was measured in a sodium-free and potassium-free solution.
Isolated myocytes were placed in a chamber mounted on an inverted microscope (Nikon
Diaphot) and perfused with 1mM calcium-containing Tyrode solution. Both the inflow
solution and the chamber were water-heated to maintain the temperature at 36±1°C. A
4-5 MΩ pipette filled with a Cs+-containing solution [composition in mM: 130 Csaspartate, 10 N-methyl-Dglucamine (NMDG), 20 tetraethylammonium chloride, 10
HEPES, 2.5 Tris-ATP, 1 MgCl2, and 10 EGTA, pH 7.2] was used to obtain gigaseals.
Once a gigaseal was formed, the patch was ruptured and the cell was dialyzed for 10
min. The extracellular bath was then changed to a 2mM calcium -containing Cs+
substitution bath solution (composition in mM: 2 4-aminopyridine, 2 CaCl2, 5.4 CsCl, 10
glucose, 5 HEPES, 1.2 MgCl2, and 150 NMDG, pH 7.4 with CsOH). Membrane voltage
was controlled by an Axopatch 2A voltage-clamp amplifier and digitized by Digidata
1322 using pClamp8 software (Molecular Devices). Once the signal was converted to
digital format, it was stored on a personal computer for off-line analysis with Clampfit 10
(Axon Instruments). The flow of the bathing solution was 2–3 ml/min 4.
Fractional Shortening Magnitude, Ca2+ Transients and SR Load Measurements
Fractional Shortening Magnitude and transients were measured simultaneously in
myocytes incubated with Tyrodes solution containing 1mM Ca2+ at rates of 0.5 and 2 Hz
stimulation with an edge detector. [Ca2+]i were measured in paced myocytes loaded with
Fluo-4AM as described in previous studies 5. Once a steady state had been reached, 10
and 100nM Isoproterenol (Iso) was applied through the perfusion solution. Once a stable
effect of Iso had been achieved, at least 20 continuous contractions and Ca2+ transients
were recorded and averaged for analysis. Ca2+ transients were fit with a singleexponential decay function to determine the decay rate. To measure SR Ca2+ content,
myocytes were paced at 0.5 Hz for 10 consecutive contractions, and 10 mM caffeine
was then rapidly applied via a glass pipette close to the myocyte with a Pico spritzer 6-7.
Since caffeine cannot be repetitively applied on the same cell, the SR Ca2+ content after
10nM Iso was measured by a caffeine spritz after stable effects of Iso on myocyte
contraction and Ca2+ transients had been observed.
In vivo hemodynamic measurements Mice were anesthetized with a 2% Isoflurane
and the right common carotid artery was isolated and cannulated with 1.4 French
micromanometer (Millar Instruments, Houston, TX). LV pressure, LV end-diastolic
pressure (LVEDP) and heart rate (HR) were measured by this catheter advanced into
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the LV cavity, and data was recorded and analyzed on a PowerLab System (AD
Instruments Pty Ltd., Mountain View, CA). These parameters as well as maximal values
of the instantaneous first derivative of LV pressure (+dP/dtmax, as a measure of cardiac
contraction) and minimum values of the instantaneous first derivative of LV pressure (dP/dtmin, as a measure of cardiac relaxation) were recorded at baseline and after
administration of the β-adrenergic receptor (βAR) agonist, isoproterenol (Iso, 2ug/Kg and
2mg/Kg i.p. injection)
Western Blotting Cytoplasmic and membrane protein were isolated from ventricular
tissue using PBS lysis buffer containing: 0.5% Triton X-100, 5 mM EDTA (pH7.4),
phosphatase inhibitors (10 mM NaF and 0.1 mM NaVO4), proteinase inhibitors (10 μg/ml
aprotinin, 10 μg/ml leupeptin, 1mM phenylmethylsulfonyl fluoride, 5 μg/ml pepstatin A, 8
μg/ml calpain inhibitor I & II, and 200 μg/ml benzamidine). Cardiac actin was isolated
from resulting pellet using PBS lysis buffer containing 2% sodium dodecyl sulfate, SDS
(FisherBiotech), 1% IGEPAL CA-630 (Sigma), 0.5 % deoxycholate (Sigma), 5 mM EDTA
(pH 7.4), and proteinase inhibitors. Protein abundance and phosphorylation levels in
isolated protein were analyzed with Western blot analysis as described previously 8.
Target antigens were probed with the following antibodies: phospholamban (PLB)
(Upstate Biotechnology), RyR (Research Diagnostics), α-sarcomeric actin (Sigma),
LTCC-α1C subunit (Chemicon), GAPDH (Serotec), PS2809-RyR, PS16-PLB, and PT17PLB (Badrilla).
Statistics
Data are presented as mean±SEM. Between-group comparisons were
performed by using the one way ANOVA or t-test. For all tests, statistical significance
was set at P<0.05.
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Onlinel Figure I A. Representative images of cardiac tissue sections stained with TTC
after 4 weeks MI. B. Representative images of fixed hearts and middle cross sections with
infarct zone. C. Representative cardiac histology tissue sections with H&E staining after 4
weeks MI.
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Online Figure II Representative Western blots of Ca2+ regulatory proteins in
heart tissues from WT and S2808A mice 4 weeks after sham or MI-operated
procedure.
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Online Figure III A. Voltage dependence of ICa,L activation in sham WT (n=6)
and S2808A myocytes (n=5) +/- Iso (1umol/L). B. Voltage dependence of ICa,L
activation in post-MI WT (n=6) and S2808A myocytes (n=5) +/- Iso (1umol/L).
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Online Figure IV A-B. Representative traces of sham and post-MI myocyte contractions
-/+ Iso (100nmol/L) at 0.5 Hz pacing rate from WT and S2808A hearts. C-D.
Representative traces of sham and post-MI myocyte contractions -/+ Iso (100nmol/L) at 2
Hz pacing rate from WT and S2808A hearts.
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Online Figure V A-B. Representative traces of sham and post-MI myocyte Ca2+
transients -/+ Iso (100nmol/L) at 0.5 Hz pacing rate from WT and S2808A hearts. C-D.
Representative traces of sham and post-MI myocyte Ca2+ transients -/+ Iso (100nmol/L)
at 2 Hz pacing rate from WT and S2808A hearts.
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Online Figure VI A. Cardiac function (dP/dT ) with Isoproterenol treatment (2ug/Kg and
2mg/Kg i.p.injection) was determined by hemodynamics measurement using Miller
catheterization. B. Peak dP/dT after Iso treatment was assessed in WT and S2808A mice.
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